Qiang Sun

6PUBLICATIONS
7CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 11, 2025
Prognostic value of the systemic immune-inflammation index in recurrent/metastatic triple-negative breast cancer: a retrospective cohort study.

Jialin Zhao, Xing Chen, Zijuan Zhang

|Mar 15, 2022
Rationale and design of a phase II trial of pyrotinib in combination with nab-paclitaxel as adjuvant therapy for N0/N1mi, HER2 + early breast cancer (PHAEDRA).

Changjun Wang, Yidong Zhou, Yan Lin

|Nov 12, 2021
Breast-conserving therapy for breast cancer with BRCA mutations: a meta-analysis.

Changjun Wang, Yan Lin, Hanjiang Zhu

|May 18, 2021
Serial circulating tumor DNA identification associated with the efficacy and prognosis of neoadjuvant chemotherapy in breast cancer.

Yidong Zhou, Yaping Xu, Changjun Wang

|Jul 15, 2020
Pyrotinib with trastuzumab and aromatase inhibitors as first-line treatment for HER2 positive and hormone receptor positive metastatic or locally advanced breast cancer: study protocol of a randomized controlled trial.

Changjun Wang, Yan Lin, Yidong Zhou

|Oct 03, 2018
Would 1.0 cm be a more suitable cutoff to subdivide pT1 tumors in hormone receptor-negative and HER2-positive breast cancer?

Changjun Wang, Yidong Zhou, Hanjiang Zhu

Pageof 1

Frequent Collaborators

1 joint publications

Jialin Zhao

1 joint publications

Xing Chen

1 joint publications

Zijuan Zhang

1 joint publications

Dachun Zhao